814 W Diamond Ave Suite 203, Gaithersburg MD 20878
Tel. +1 703-677-8457 Fax. +1 240-474-5660
Mail - info@aevisbio.com
125 Gwahak-ro KRIBB, Venturedong #314-315,
Yuseong-gu, Daejeon, Republic of Korea
Tel. +82-70-7500-4815 Fax. +82-70-7500-4816
16 Daewangpangyo-ro 712 beon-gil IPK, Research Building 3rd Floor, Bundang-gu, Seongnam-si, Gyeonggi-do, 13488 Republic of Korea
Tel. +82-70-4227-4569 Fax. +82-31-704-5995
2021-01-11
Aevisbio and NIH signed the patent license agreement in relation to the development of thalidomide analogues for the treatment of neurological disorders. In accordance of CRADA, Aevisbio and NIH will collaborate to develop the thalidomide analogues in pre-clinical and clinical stages.